Management of Urinary Incontinence with Scarred Open Urethra
For patients with urinary incontinence associated with a scarred open urethra, the next step in management should be referral for surgical intervention with an artificial urinary sphincter (AUS) placement as the preferred treatment option. 1
Assessment of Urethral Condition
When evaluating a patient with urinary incontinence and a scarred open urethra, it's important to understand the underlying pathophysiology:
- The scarred open urethra indicates significant structural damage to the urethral closure mechanism
- This represents a severe form of intrinsic sphincter deficiency
- Conservative measures are unlikely to be effective in this scenario due to the anatomical defect
Treatment Algorithm
First-line Surgical Options
Artificial Urinary Sphincter (AUS)
- Gold standard for severe incontinence with compromised urethral integrity 1
- Provides circumferential compression of the urethra
- Most effective option for patients with scarred/open urethra
- Success rates significantly higher than other interventions for severe cases
Autologous Fascial Sling
- Alternative when AUS is contraindicated or unavailable
- Particularly useful in patients with poor tissue quality 1
- Avoids synthetic mesh in a compromised urethral environment
Contraindicated Options
Synthetic Midurethral Slings
Urethral Bulking Agents
- Unlikely to be effective with significant urethral scarring
- Requires relatively intact urethral coaptation to be effective
Special Considerations
Preoperative Evaluation
- Cystoscopy to assess the degree of urethral scarring and rule out urethral erosion
- Urodynamic testing to evaluate bladder function and confirm type of incontinence
- Assessment of manual dexterity if considering AUS (patient must be able to operate the device)
Surgical Planning
- For AUS placement, the cuff should be placed at a different location from the scarred area if possible 1
- If previous radiation or extensive scarring is present, consider delayed or staged procedures
Post-surgical Care
- AUS should remain deactivated for 4-6 weeks post-implantation to allow healing
- Regular follow-up is essential as AUS effectiveness decreases over time (24% failure at 5 years, 50% at 10 years) 1
- Patients should be counseled about potential need for revisions or replacements
Pitfalls to Avoid
Attempting conservative management alone - With a scarred open urethra, pelvic floor exercises and behavioral therapy will be insufficient 1
Placing synthetic mesh - Guidelines strongly caution against using synthetic mesh in patients with compromised tissue quality or previous urethral surgery 1
Underestimating the complexity - Management should involve urologists experienced in complex incontinence cases, particularly those skilled in AUS placement 1
Inadequate follow-up - Patients with AUS require long-term monitoring for device function and potential complications 1
By following this approach, patients with urinary incontinence and a scarred open urethra can achieve the best possible outcomes in terms of continence restoration and quality of life improvement.